Estrich Biomedic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-12-2024
- Paid Up Capital ₹ 0.10 M
as on 08-12-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2018
- Revenue -53.70%
(FY 2016)
- Profit 51.56%
(FY 2016)
- Ebitda 26.49%
(FY 2016)
- Net Worth 30.40%
(FY 2016)
- Total Assets -51.57%
(FY 2016)
About Estrich Biomedic
The Corporate was formerly known as Estrella Bio-Science Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhinav Bhargava, Bhavanaben Patel, Dharmik Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233GJ2013PTC077217
- Company No.
077217
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2013
- Date of AGM
19 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Estrich Biomedic?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav Bhargava  | Director | 15-Oct-2013 | Current |
| Bhavanaben Patel | Director | 15-Oct-2013 | Current |
| Dharmik Patel | Additional Director | 31-Mar-2017 | Current |
| Amitaben Patel | Additional Director | 31-Mar-2017 | Current |
Financial Performance and Corporate Structure Insights of Estrich Biomedic.
Estrich Biomedic Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 53.7% decrease. The company also saw a substantial improvement in profitability, with a 51.56% increase in profit. The company's net worth Soared by an impressive increase of 30.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Estrich Biomedic?
In 2017, Estrich Biomedic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanjeevani Bio-Tech Exim Private LimitedActive 14 years 6 monthsAbhinav Bhargava is a mutual person
- Sanjeevani Tech Solutions Private LimitedActive 11 years 2 months
Abhinav Bhargava is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Estrich Biomedic?
Unlock and access historical data on people associated with Estrich Biomedic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Estrich Biomedic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Estrich Biomedic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
